Sculptor Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Sculptor Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.2M	Buy	1,062,763 +353,093	+50%	+$3.74M	0.12%	155
2026 Q2	$6.66M	Sell	709,670 -249,152	-26%	-$1.35M	0.05%	183
2026 Q1	$1.7M	Buy	958,822 +780,715	+438%	+$1.51M	0.02%	241
2025 Q4	$163K	Hold	178,107	–	–	﹤0.01%	324
2025 Q3	$50.3K	Hold	178,107	–	–	﹤0.01%	327
2025 Q2	$41.8K	Hold	178,107	–	–	﹤0.01%	338
2025 Q1	$9.5K	Hold	178,107	–	–	﹤0.01%	306
2024 Q4	$30.3K	Hold	178,107	–	–	﹤0.01%	291
2024 Q3	$25.8K	Hold	178,107	–	–	﹤0.01%	281
2024 Q2	$18.3K	Hold	178,107	–	–	﹤0.01%	274
2024 Q1	$33.8K	Hold	178,107	–	–	﹤0.01%	254
2023 Q4	$61K	Buy	+178,107	New	+$79.6K	﹤0.01%	256

Other funds holding RVMDW

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Sculptor Capital's RVMDW Position: Q3 2026 in Review

Sculptor Capital increased its Revolution Medicines Inc Warrant (RVMDW) stake by 50% in Q3 2026, buying an estimated $3.74M and bringing the position to 1,062,763 shares worth $12.2M. The position accounts for 0.12% of the portfolio, ranked #155.

Sculptor Capital first reported a position in RVMDW in Q4 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold RVMDW as of Q3 2026.

Sculptor Capital held 1,062,763 shares of Revolution Medicines Inc Warrant worth $12.2M as of Q3 2026.
Sculptor Capital bought 353,093 Revolution Medicines Inc Warrant shares in Q3 2026, an estimated $3.74M.
Revolution Medicines Inc Warrant made up 0.12% of Sculptor Capital's portfolio in Q3 2026, its #155 holding.
Sculptor Capital first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 12 quarters since.
8 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q3 2026.

Based on Sculptor Capital's 13F filing for Q3 2026, filed 13 Nov 2026.